Carregant...
“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
PURPOSE: To report the association of pembrolizumab, an immune checkpoint inhibitor (ICI), with giant cell arteritis (GCA) presenting as paracentral acute middle maculopathy (PAMM) secondary to retinal arterial occlusion. OBSERVATIONS: 86-year old male with history of treated choroidal melanoma now...
Guardat en:
| Publicat a: | Am J Ophthalmol Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7472807/ https://ncbi.nlm.nih.gov/pubmed/32913923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100891 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|